| Literature DB >> 34923963 |
Tzu-Hung Liu1,2, Andrew D Ho3, Yu-Tien Hsu4, Chih-Cheng Hsu5.
Abstract
BACKGROUND: Our study aims to provide validity evidence for the EuroQol five dimensions questionnaire (EQ-5D) in the National Health Interview Survey of Taiwan in the 2013 wave and further interpret the EQ-5D scores for patients with chronic diseases. Another goal of the study was to use item response theory (IRT) to identify items that are informative for assessing quality of life using EQ-5D.Entities:
Keywords: EQ-5D (EuroQol-5 dimensions); IRT (Item response theory); NHIS (National Health Interview Survey); Taiwan; Validity
Mesh:
Year: 2021 PMID: 34923963 PMCID: PMC8684691 DOI: 10.1186/s12889-021-12334-y
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Baseline characteristics of interviewees in NHIS-Taiwan (n=17,260)
| Mean | SD | Min | Max | |
|---|---|---|---|---|
| Age (yrs) | 38.12 | 15.94 | 12.01 | 65.00 |
| Sex | Male: 48.92%, Female: 51.08% | |||
| Marital status | Married: 48.91%, Separated: 2.25%, Divorced: 4.76%, Widowed: 2.72%, Never married: 41.15% | |||
| Education | High school diploma: 32.81%, Bachelor's degree: 33.82%, Graduate school education: 5.21%, Less than a high school education: 28.11% | |||
| Chronic Disease(s) | Yes: 21.32% (3,677), No: 78.68% (13,566) | |||
| For those who had chronic disease(s) | ||||
| Have ever had the disease | Hypertension | Yes: 41.63% (1,530), No: 58.37% (2,145) | ||
| Diabetes | Yes: 19.94% (732), No: 80.06% (2939) | |||
| Dyslipidemia | Yes: 33.59% (1222), No: 66.41% (2416) | |||
| Stroke | Yes: 3.75% (138), No: 96.25% (3538) | |||
| Asthma | Yes: 6.90% (254), No: 93.06% (3422) | |||
| Chronic kidney disease | Yes: 9.60% (352), No: 90.40% (3316) | |||
| Have had the disease during the past yeara | Heart disease | Yes: 11.62% (427), No: 88.38% (3248) | ||
| Gout | Yes: 8.89% (327), No: 91.11% (3350) | |||
| Peptic ulcer | Yes: 9.68% (356), No: 90.29% (3320) | |||
| COPD | Yes: 2.31% (85), No: 97.69% (3591) | |||
| Liver/gall bladder disease | Yes: 13.63% (501), No: 86.37% (3174) | |||
| Osteoporosis | Yes: 12.33% (453), No: 87.67% (3221) | |||
| Cancer | Yes: 3.24% (119), No: 96.76% (3558) | |||
| Osteoarthritis | Yes: 9.28% (341), No: 90.72% (3332) | |||
| Psychiatric disorder | Yes: 8.82% (324), No: 91.18% (3350) | |||
| BPH (male) | Yes: 7.55% (153), No: 92.45% (1874) | |||
| Uterine/ovarian disease (female) | Yes: 7.55% (124), No: 92.45% (1519) | |||
aCOPD Chronic obstructive pulmonary disease, BPH Benign prostatic hyperplasia
Parameters of the graded response model
| Domaina | Information parameter | Location parameter |
|---|---|---|
| D1 | 6.56 | -2.24 |
| D2 | 7.44 | -2.58 |
| D3 | 8.66 | -2.19 |
| D4 | 1.94 | -1.72 |
| D5 | 1.98 | -2.35 |
| D6 | 1.49 | -5.67, -4.70, -4.42, -4.05, -3.60, -2.61, -1.74, -0.91, 0.29, 1.70 |
aD1-D5 rescaled as 0 (for those who answered 2 or 3) and 1; D6 rescaled as 0-10 (0 stands for less than 5; 1 stands for 5-15; … ; 10 stands for more than 95)
Fig. 1Histograms of the health-related quality of life (EQ-5D scale score) for groups with and without chronic diseases
EQ-5D scale score for specific disease groups (from low to high)
| Disease* | Mean (SD) | ||
|---|---|---|---|
| Stroke | -1.04 (1.25) | -0.45 (0.90) | |
| Psychiatric disorder | -0.91 (0.93) | -0.41 (0.95) | |
| COPD | -0.72 (0.94) | -0.38 (0.82) | |
| Cancer | -0.70 (0.98) | -0.37 (0.86) | |
| Osteoarthritis | -0.69 (0.94) | -0.37 (0.92) | |
| Heart disease | -0.56 (0.92) | -0.33 (0.83) | |
| Osteoporosis | -0.52 (0.95) | -0.32 (0.85) | |
| Diabetes | -0.50 (0.87) | -0.25 (0.82) | |
| Hyperlipidemia | -0.49 (0.97) | ||
COPD Chronic obstructive pulmonary disease, BPH Benign prostatic hyperplasia
Fig. 2Item information function plots for 6 items in EQ-5D in the graded response model
Correlation coefficients between EQ-5D and SF-36 scores (n=8,272)
| SF-36 Physical component score (PCS) | SF-36 Mental component score (MCS) | SF-36 | |
|---|---|---|---|
| 0.63 | 0.46 | 0.61 | |
| 0.62-0.65 | 0.44-0.48 | 0.60-0.62 | |
| 0.47 | 0.42 | 0.50 | |
| 0.45-0.49 | 0.40-0.44 | 0.48-0.51 | |
| 0.60 | 0.48 | 0.61 | |
| 0.59-0.62 | 0.47-0.50 | 0.59-0.62 |